Table 1.
Patients’ characteristics
| Characteristic | NEO (n = 175) | SUG (n = 175) | P value |
|---|---|---|---|
| Sex, M/F, n (%) | 117 (66.9)/58(33.1) | 104 (59.4)/71 (40.6) | 0.184 |
| Age, years [IQR] | 52 [40.5-63] | 52 [43.5-60] | 0.654 |
| Height, cm [IQR] | 170 [165-176] | 170 [164-176] | 0.355 |
| Weight, kg [IQR] | 70 [62-80] | 68 [55-78] | 0.186 |
| BMI, kg/m2 [IQR] | 24.22 [22-26.2] | 23.6 [20.4-26.1] | 0.194 |
| ASA, II/III/IV, n (%) | 34 (19.4)/137(78.3)/4 (2.3) | 26 (14.9)/148(84.6)/1 (0.6) | 0.197 |
| Neurovascular disease, n (%) | 6 (3.4) | 10 (5.7) | 0.444 |
| Respiratory disease, n (%) | 18 (10.3) | 26 (14.9) | 0.195 |
| • Obstructive, n (%) | 8 (4.6) | 11 (6.3) | 0.638 |
| • Other, n (%) | 10 (5.7) | 15 (8.6) | 0.407 |
| Cardiovascular disease, n (%) | 137 (78.3) | 147 (84) | 0.219 |
| • Hypertension, n (%) | 124 (70.9) | 130 (74.3) | 0.549 |
| • Other, n (%) | 13 (7.9) | 17 (9.7) | 0.529 |
| Abdominal disease, n (%) | 63 (36) | 79 (45.1) | 0.102 |
| Impaired glucose tolerance, n (%) | 25 (14.3) | 30 (17.1) | 0.557 |
| Dyslipidaemia, n (%) | 30 (17.1) | 32 (18.3) | 0.889 |
| Other disease, n (%) | 16 (9.1) | 13 (7.4) | 0.699 |
| Previous KTx, n (%) | 18 (10.3) | 16 (9.1) | 0.857 |
NMB neuromuscular block, NEO group of patients receiving neostigmine for reversal of cisatracurium-induced NMB, SUG group of patients receiving sugammadex for reversal of rocuronium-induced NMB, M male, F female, BMI body mass index, ASA American Society of Anesthesiologists physical status; neurovascular disease: history of transient ischemic attack, stroke, cerebral hemorrhage; respiratory disease: history of asthma, chronic obstructive pulmonary disease, or other diseases (restrictive lung diseases); cardiovascular disease: history of coronary artery disease, arrhythmia, heart failure, hypertension, disorders of the peripheral vascular system; abdominal disease: gastrointestinal disease (history of peptic ulcer, gastroesophageal reflux disease, irritable bowel syndrome, diverticular diseases, colitis, anal disease) and liver disease; other disease: rheumatic disease and musculoskeletal disease. Previous KTx previous kidney transplantation. Data are expressed as median [interquartile range, IQR] or number, n (%)